Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018 by Zhengjin Wang, Zhangxin Chen, Zhangxin Chen, Hanxu Zhuang

Subjects: Get full text

Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus by Fangyu Li, Rui Li, Hongjun Deng

Subjects: Get full text

Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysis by Hongkun Yin, Xusheng Zhang, Qi Wang

Subjects: “…MASLD…”
Get full text

Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD by Ester S. Alves, Jessica D. M. Santos, Alessandra G. Cruz, Felipe N. Camargo, Carlos H. Z. Talarico, Anne R. M. Santos, Carlos A. A. Silva, Henrique J. N. Morgan, Sandro L. Matos, Layanne C. C. Araujo, João Paulo Camporez

Subjects: Get full text

Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease by Ana Paula Madariaga Traconis, Misael Uribe-Esquivel, Varenka Julieta Barbero Becerra

Subjects: Get full text

Gender difference in the association between serum uric acid and metabolic dysfunction-associated steatotic liver disease in patients with newly diagnosed type 2 diabetes by Yuliang Cui, Zhenzhen Qu, Lingling Li, Wenmei Hu

Subjects: Get full text

Akkermansia muciniphila ameliorates olanzapine-induced metabolic dysfunction-associated steatotic liver disease via PGRMC1/SIRT1/FOXO1 signaling pathway by Hui Chen, Hui Chen, Hui Chen, Hui Chen, Hui Chen, Ting Cao, Ting Cao, Ting Cao, Ting Cao, ChenQuan Lin, ChenQuan Lin, ChenQuan Lin, ShiMeng Jiao, ShiMeng Jiao, ShiMeng Jiao, YiFang He, YiFang He, YiFang He, ZhenYu Zhu, ZhenYu Zhu, ZhenYu Zhu, QiuJin Guo, QiuJin Guo, QiuJin Guo, RenRong Wu, HuaLin Cai, HuaLin Cai, HuaLin Cai, HuaLin Cai, BiKui Zhang, BiKui Zhang, BiKui Zhang

Subjects: Get full text

Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease by Sofia Schaeffer, Sofia Schaeffer, Andrijana Bogdanovic, Talitha Hildebrandt, Emilio Flint, Anne Geng, Sylvia Pecenko, Paul Lussier, Michael A. Strumberger, Martin Meyer, Jakob Weber, Markus H. Heim, Markus H. Heim, Christian Cajochen, Christine Bernsmeier, Christine Bernsmeier

Subjects: “…MASLD…”
Get full text

Gout drives metabolic dysfunction-associated steatotic liver disease through gut microbiota and inflammatory mediators by Siyuan Liu, Fan Li, Yunjia Cai, Lin Sun, Linan Ren, Mengsha Yin, Huijuan Cui, Yujie Pan, Xiaokun Gang, Guixia Wang

Subjects: Get full text

<i>Lactobacillus</i> sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice by Titilayo Olotu, Jessica M. Ferrell

Subjects: “…MASLD…”
Get full text

Intercellular adhesion molecule-1 protects against adipose tissue inflammation and insulin resistance but promotes liver disease activity in western-diet fed mice by Sreepradha Eswaran, Laura Gebert, Sarah Schraven, Nicole Treichel, Thomas Ritz, Sabine Hamm, Agnes Seeger, Fabian Kiessling, Thomas Clavel, Stephan Dreschers, Norbert Wagner, Angela Schippers

Subjects: Get full text

Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated a... by Peng Wang, Bingxin Xia, Shuang Wang

Subjects: “…MASLD…”
Get full text

AI‐Based Platelet‐Independent Noninvasive Test for Liver Fibrosis in MASLD Patients by Shun‐ichi Wakabayashi, Takefumi Kimura, Nobuharu Tamaki, Takanobu Iwadare, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Naoki Tanaka, Masayuki Kurosaki, Takeji Umemura

Subjects: Get full text

The associations between diet-induced inflammation and the improvement or worsening of hepatic steatosis and fibrosis: a longitudinal analysis of RaNCD cohort study by Mohammad Sedighi, Amir Saber, Amir Bagheri, Saba Hazratian, Yahya Pasdar, Farid Najafi, Mehdi Moradinazar, Davood Soleimani

Subjects: Get full text

An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD):... by Taranika Sarkar Das, Xucong Meng, Mohamed Abdallah, Mohammad Bilal, Raiya Sarwar, Aasma Shaukat

Subjects: Get full text

Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD by Julia Frączek, Aleksandra Sowa, Paulina Agopsowicz, Maciej Migacz, Katarzyna Dylińska-Kala, Michał Holecki

Subjects: “…MASLD…”
Get full text

Pentraxin-3 as a poor marker of fibrosis in metabolic dysfunction-associated steatotic liver disease among older adults: findings from the PolSenior2 substudy by Aleksander Jerzy Owczarek, Joanna Musialik, Adrian Stefański, Małgorzata Mossakowska, Katarzyna Zięba, Andrzej Więcek, Jerzy Chudek, Magdalena Olszanecka-Glinianowicz

Subjects: Get full text

Multiparametric MRI assessment of renal blood oxygenation, fat content, and hemodynamics in an animal model of metabolic dysfunction-associated steatotic liver disease by Chao Wang, Chao Wang, Jiaming Qin, Hongtao Yuan, Jin Zhou, Ting Cao, Jinxia Zhu, Simeng Kang, Shuangshuang Xie, Wen Shen

Subjects: Get full text

Discrepancy in Metabolic Dysfunction–Associated Steatotic Liver Disease Prevalence in a Large Northern California Cohort by Luis A. Rodriguez, Lue-Yen S. Tucker, Varun Saxena, Theodore R. Levin

Subjects: “…MASLD Prevalence…”
Get full text

Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD by Tianyuan Yang, Bingqing Yang, Jingya Yin, Chenxue Hou, Qi Wang

Subjects: “…MASLD…”
Get full text